PureTech Health (PureTech Health) EV-to-EBIT : -22.00 (As of Jun. 01, 2024)

View and export this data going back to 2020. Start your Free Trial

What is PureTech Health EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, PureTech Health's Enterprise Value is $497.49 Mil. PureTech Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-22.62 Mil. Therefore, PureTech Health's EV-to-EBIT for today is -22.00.

The historical rank and industry rank for PureTech Health's EV-to-EBIT or its related term are showing as below:

PRTC' s EV-to-EBIT Range Over the Past 10 Years
Min: -22.35 Med: -2.58 Max: 59.05
Current: -22

During the past 12 years, the highest EV-to-EBIT of PureTech Health was 59.05. The lowest was -22.35. And the median was -2.58.

PRTC's EV-to-EBIT is ranked worse than
100% of 423 companies
in the Biotechnology industry
Industry Median: 10.04 vs PRTC: -22.00

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. PureTech Health's Enterprise Value for the quarter that ended in Dec. 2023 was $458.45 Mil. PureTech Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-22.62 Mil. PureTech Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -4.93%.

PureTech Health EV-to-EBIT Historical Data

The historical data trend for PureTech Health's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PureTech Health EV-to-EBIT Chart

PureTech Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

2.19

54.46

-12.82

-6.83

-15.95

PureTech Health Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															-12.82	-	-6.83	-	-15.95

Competitive Comparison of PureTech Health's EV-to-EBIT

For the Biotechnology subindustry, PureTech Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PureTech Health's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PureTech Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PureTech Health's EV-to-EBIT falls into.

PureTech Health EV-to-EBIT Calculation

PureTech Health's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	497.494	/	-22.615
	=	-22.00

PureTech Health's current Enterprise Value is $497.49 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PureTech Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-22.62 Mil.

PureTech Health (NAS:PRTC) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

PureTech Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-22.615	/	458.449572
	=	-4.93 %

PureTech Health's Enterprise Value for the quarter that ended in Dec. 2023 was $458.45 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PureTech Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-22.62 Mil.

PureTech Health EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of PureTech Health's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

PureTech Health (PureTech Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PureTech Health PLC (NAS:PRTC) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

PTCHF:USA PRTCl:UK PRTC:UK PRTCL:Germany

Address

6 Tide Street, Suite 400, Boston, MA, USA, 02210

Website

https://www.puretechhealth.com

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.